Peer-reviewed Artikel
Gene Ther. 2011 Apr;18(4):418-23.
Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models. Gene Ther. 2011 Apr;18(4):418-23.
Schmidt A, Eipel C, Fürst K, Sommer N, Pahnke J, Pützer BM.Virol J. 2010 Nov 18;7(1):327.
Functional dissection of the alphavirus capsid protease: sequence requirements for activity.
Thomas S, Rai J, John L, Gunther S, Drosten C, Pützer BM, Schäfer S. Expert Rev Anticancer Ther. 2010 Nov;10(11):1707-1720.
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.
Pützer BM, Steder M, Alla V.Cell Death Differ. 2011 May;18(5):874-86.
GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
John K, Alla V, Meier C, Pützer BM.Drug Res Updates. 2010 Aug-Oct;13(4-5):119-31.
Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
Engelmann D, Pützer BM.Brain Struct Funct. 2010 Aug;215(2):105-13.
Targeting of neural stem cells in the hippocampus of adult rats by custom-made Ad vectors.
Hildebrandt S, Schmidt A, Stoll A, Schmitt O, Köhling R, Wree A, Haas SJP, Pützer BM.Cell Cycle. 2010; 9(13):2555-2567.
Checks and balances: E2F – microRNA crosstalk in cancer control.
Emmrich S, Pützer BM.J Nat Cancer Inst. 2010;102(2):127-133.
E2F1 in melanoma progression and metastasis.
Alla V, Engelmann D, Niemetz A, Pahnke J, Schmidt A, Kunz M, Emmrich S, Steder M, Koczan D, Pützer BM.Cell Mol Life Sci. 2010 Mar;67(6):931-48.
Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.
Engelmann D, Knoll S, Ewerth D, Steder M, Stoll A, Pützer BM.Molecular Cancer. 2009; 8:61 doi:10.1186/1476-4598-8-61.
